171 related articles for article (PubMed ID: 31606778)
1. Natural killer cells control metastasis via structural editing of primary tumors in mice.
Isaacson B; Mandelboim O
Cancer Immunol Immunother; 2019 Oct; 68(10):1721-1724. PubMed ID: 31606778
[TBL] [Abstract][Full Text] [Related]
2. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
[TBL] [Abstract][Full Text] [Related]
3. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
4. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.
Glasner A; Isaacson B; Viukov S; Neuman T; Friedman N; Mandelboim M; Sexl V; Hanna JH; Mandelboim O
Sci Rep; 2017 Oct; 7(1):13090. PubMed ID: 29026144
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
[TBL] [Abstract][Full Text] [Related]
6. Virus-mediated inhibition of natural cytotoxicity receptor recognition.
Seidel E; Glasner A; Mandelboim O
Cell Mol Life Sci; 2012 Dec; 69(23):3911-20. PubMed ID: 22547090
[TBL] [Abstract][Full Text] [Related]
7. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
[TBL] [Abstract][Full Text] [Related]
8. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O
Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644
[TBL] [Abstract][Full Text] [Related]
9. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
10. Regulation of self-ligands for activating natural killer cell receptors.
Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
[TBL] [Abstract][Full Text] [Related]
11. Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30.
Luczo JM; Ronzulli SL; Tompkins SM
Viruses; 2021 Jan; 13(2):. PubMed ID: 33494528
[TBL] [Abstract][Full Text] [Related]
12. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
[TBL] [Abstract][Full Text] [Related]
13. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.
Nowbakht P; Ionescu MC; Rohner A; Kalberer CP; Rossy E; Mori L; Cosman D; De Libero G; Wodnar-Filipowicz A
Blood; 2005 May; 105(9):3615-22. PubMed ID: 15657183
[TBL] [Abstract][Full Text] [Related]
14. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy.
Costello RT; Boehrer A; Sanchez C; Mercier D; Baier C; Le Treut T; Sébahoun G
Immunology; 2013 Jul; 139(3):338-41. PubMed ID: 23360454
[TBL] [Abstract][Full Text] [Related]
16. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the mechanisms of influenza virus recognition by Ncr1.
Glasner A; Zurunic A; Meningher T; Lenac Rovis T; Tsukerman P; Bar-On Y; Yamin R; Meyers AF; Mandeboim M; Jonjic S; Mandelboim O
PLoS One; 2012; 7(5):e36837. PubMed ID: 22615821
[TBL] [Abstract][Full Text] [Related]
18. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
Koch J; Steinle A; Watzl C; Mandelboim O
Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
[TBL] [Abstract][Full Text] [Related]
19. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Glasner A; Levi A; Enk J; Isaacson B; Viukov S; Orlanski S; Scope A; Neuman T; Enk CD; Hanna JH; Sexl V; Jonjic S; Seliger B; Zitvogel L; Mandelboim O
Immunity; 2018 Jan; 48(1):107-119.e4. PubMed ID: 29329948
[TBL] [Abstract][Full Text] [Related]
20. The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes.
Enk J; Mandelboim O
Front Immunol; 2014; 5():4. PubMed ID: 24478773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
